Related Herbs
Botanicals connected by the same goals, effects, or research topics.
Herb Profile
Cyclea peltata
Cyclea Peltata (Cyclea peltata) carries a Grade C rating — limited evidence.
Use extra caution — Alkaloid rich traditional herb; human safety data are limited. Details
Continue reading
Safety
Alkaloid rich traditional herb; human safety data are limited. Avoid pregnancy/breastfeeding and unsupervised high dose use.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
Evidence
Read as directional context, not settled clinical proof.
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · NF KB Modulation
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — Alkaloid rich traditional herb; human safety data are limited.
This profile cites 3 human studies.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
What the evidence actually shows
This table contains 3 structured sources, including 0 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Protective effect of Cyclea peltata Lam on cisplatin-induced nephrotoxicity and oxidative damage Vijayan FP et al. · J Basic Clin Physiol Pharmacol · 2007 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Gastric antisecretory and antiulcer activities of Cyclea peltata (Lam.) Hook. f. & Thoms. in rats Shine VJ et al. · J Ethnopharmacol · 2009 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Cheni Cheri D et al. · J Cosmet Dermatol · 2022 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Cyclea Peltata Works
Key constituents studied in Cyclea Peltata, with full pharmacology and safety profiles.
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Condition guides
Compare side-by-side tradeoffs or verify active marker guidelines.
Continue comparing
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.